by cecile.rousselot@eurobiomed.org | Sep 26, 2024 | News, Member
Inhibit cell death to save the myocardium and the patient's life during a heart attack. Created in September 2023 in Montpellier, ApoRepair capitalizes on a family of patents from the CNRS in Montpellier. It offers treatment for lesions...
by cecile.rousselot@eurobiomed.org | Sep 26, 2024 | News, Member
Created in 2013 and based in Grabels (34) and Labège (31), Adelis is an analytical instrumentation company which manufactures and markets a wide range of fluorescence detectors induced by LED and laser as well as hair electrophoresis equipment ...
by cecile.rousselot@eurobiomed.org | Jul 29, 2024 | News, Member
The Max Delbrück Center, Berlin, and the biotech company AlgenScribe from France have agreed to cooperate to further develop their gene-editing tools. The aim is to utilize synergies, accelerate research, and ultimately develop cell therapies for genetically...
by cecile.rousselot@eurobiomed.org | Jul 24, 2024 | Member
Created in Toulouse in 2005, Abionyx Pharma is a new generation biotech company listed on Euronext Paris (FR0012616852 - ABNX - Eligible PEA PME) dedicated to the discovery and development of innovative biotherapies. His portfolio of ...
